JP Morgan Maintains Overweight on Insulet, Raises Price Target to $200

JP Morgan maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $170 to $200.

Benzinga · 12/20/2019 14:36

JP Morgan maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $170 to $200.